Trends in the use of topical over the counter products in the management of dermatologic disease in the United States

Dermatology Online Journal

Volumn 18, Issue 2, 2012, Pages

  Nolan, Bridgit V ^a   Levender, Michelle M ^a   Davis, Scott A ^a   Feneran, Ashley N ^a   Fleischer, Alan B ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; BACITRACIN PLUS NEOMYCIN PLUS POLYMYXIN B; BACITRACIN PLUS POLYMYXIN B; BENZOYL PEROXIDE; CETAPHIL; CLOTRIMAZOLE; HYDROCORTISONE; HYDROQUINONE; LANOLIN ALCOHOL; LUBRIDERM; NEUTROGENA; NON PRESCRIPTION DRUG; POLYSPORIN; SALICYLIC ACID; SULFACETAMIDE; SUNSCREEN; TAR; UNCLASSIFIED DRUG; XIPAMIDE;

ACNE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DEMOGRAPHY; DERMATOLOGIST; ECZEMA; HEALTH SURVEY; HUMAN; HUMIDIFIER; MEDICAL RECORD; MEDICAL SPECIALIST; PSORIASIS; ROSACEA; SKIN DISEASE; UNITED STATES; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEY; MALE; STATISTICS;

DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; NONPRESCRIPTION DRUGS; SKIN DISEASES; UNITED STATES;

EID: 84857872838     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Regulation of nonprescription products. Food and Drug Administration. 2011. Ref Type: Internet Communication
2. Attitudes and beliefs about the use of over-the-counter medicines: a dose of reality. Harris Interactive/National Council on Patient Information and Education. 2011. Ref Type: Internet Communication
3. Primary prevention in the adult. American Heart Association. 2011. Ref Type: Internet Communication
4. OTC Retail Sales-1964-2009. Consumer Health Products Association. 2011. Ref Type: Internet Communication
5. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-44.
6. Johnson ML. Defining the burden of skin disease in the United States--a historical perspective. J Investig Dermatol Symp Proc 2004;9:108-10.
7. Fleischer AB, Jr., Feldman SR, Bradham DD. Office-based physician services provided by dermatologists in the United States in 1990. J Invest Dermatol 1994;102:93-7.
8. OTC Sales by Category-2006-2009. Consumer Health Products Association. 2011. Ref Type: Internet Communication
9. Vogel CA, Balkrishnan R, Fleischer AB, Cayce KA, Feldman SR. Over-the-counter topical skin products--a common component of skin disease management. Cutis 2004;74:55-67.
10. Hanifin JM. Guidelines of care for atopic dermatitis. American Academy of Dermatology. 2011. Ref Type: Internet Communication
11. Stern RS. The pattern of topical corticosteroid prescribing in the United States, 1989-1991. J Am Acad Dermatol 1996;35:183-6.
12. Friedlander SF, Hebert AA, Allen DB. Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months. J Am Acad Dermatol 2002;46:387-93.
13. Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007;56:651-63.
14. Harper JC. Benzoyl peroxide development, pharmacology, formulation and clinical uses in topical fixed-combinations. J Drugs Dermatol 2010;9:482-7.
15. Sheth VM, Weitzul S. Postoperative topical antimicrobial use. Dermatitis 2008;19:181-9.
16. Messingham MJ, Arpey CJ. Update on the use of antibiotics in cutaneous surgery. Dermatol Surg 2005;31:1068-78.
17. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 2009;60:643-59.
18. Ghali FE. Improved clinical outcomes with moisturization in dermatologic disease. Cutis 2005;76:13-8.
19. Draelos ZD. Concepts in skin care maintenance. Cutis 2005;76:19-25.
20. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004;9:136-9.
21. McClain R, Yentzer BA, Feldman SR. Keratolytics for psoriasis: are they necessary? Dermatol Online J 2009;15:11.
22. Katz HI, Lindholm JS, Weiss JS, Shavin JS, Morman M, Bressinck R et al. Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis. Clin Ther 1995;17:390-401.
23. Andreassi L, Giannetti A, Milani M. Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients. Br J Dermatol 2003;148:134-8.
24. Griffiths CE, Finlay AY, Fleming CJ, Barker JN, Mizzi F, Arsonnaud S. A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis. J Dermatolog Treat 2006;17:90-5.
25. James KA, Burkhart CN, Morrell DS. Emerging drugs for acne. Expert Opin Emerg Drugs 2009;14:649-59.
26. Chalker DK, Shalita A, Smith JG, Jr., Swann RW. A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 1983;9:933-6.
27. Tschen EH, Katz HI, Jones TM, Monroe EW, Kraus SJ, Connolly MA et al. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris. Cutis 2001;67:165-9.
28. Leyden JJ, Hickman JG, Jarratt MT, Stewart DM, Levy SF. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. J Cutan Med Surg 2001;5:37-42.
29. Lookingbill DP, Chalker DK, Lindholm JS, Katz HI, Kempers SE, Huerter CJ et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 1997;37:590-5.
30. Draelos ZD. Improving compliance in acne treatment: benzoyl peroxide considerations. Cutis 2008;82:17-20.
31. Bikowski J. The use of therapeutic moisturizers in various dermatologic disorders. Cutis 2001;68:3-11.
32. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol 2009;129:1666-74.
33. Cancer facts and figures 2010. American Cancer Society. 2011. Ref Type: Internet Communication